Table 2.
Global (n = 35) | Non-survivors (n = 9) | Survivors (n = 26) | Statistical tests |
|
---|---|---|---|---|
χ2 Logistic regression⁎ Spearman⁎ | ||||
Categorical Variable, percentage (n) | ||||
Sex F/M | 28.6 (10) / 71.4 (25) | 22.2 (2) / 77.8 (7) | 30.8 (8) / 69.2 (18) | 0.625 |
Mortality | 25.7 (9) | |||
Nosocomial Infection | 42.9 (15) | 55.6 (5) | 38.5 (10) | 0.372 |
Antibiotics | 60.0 (21) | 66.7 (6) | 57.7 (15) | 0.636 |
HFOT | 65.7 (23) | 55.6 (5) | 69.2 (18) | 0.456 |
IMV | 82.9 (29) | 88.9 (8) | 80.8 (21) | 0.577 |
CRRT | 20.0 (7) | 33.3 (3) | 15.4 (4) | 0.246 |
Continuous variables, median (IQR25–75) | ||||
Age (years) | 66.6 (59.6–71.9) | 71.7 (67.7–72.2) | 61.6(56.6–71.6) | 0.075 |
SAPS II | 30 (24–37) | 38 (30–42) | 28 (20–36) | <0.05⁎ |
SOFA | 4 (2–5) | 5 (4.5–7.5) | 3 (2–5) | <0.05⁎ |
PCT (ng/mL) | 0.31 (0.17–0.67) | 0.67 (0.42–5.96) | 0.28 (0.09–0.64) | <0.05⁎ |
GFR (ml/min/1.73m2) | 61.9 (30–79.8) | 48.2 (26–50.6) | 69.9 (32.7–86.8) | 0.110 |
Abbreviations: PCT, Procalcitonin; GFR, Glomerular Filtration Rate; HFOT, High-Flow Oxygen Therapy; IMV, Invasive Mechanical Ventilation; CRRT, Continuous Renal Replace Therapy, IQR, Interquartile Range.
Differences with values of p < .05 were considered statistically significant.